Literature DB >> 14962135

Modulation of anti-pathogenic activity in canine-derived Lactobacillus species by carbohydrate growth substrate.

G Tzortzis1, M-L A Baillon, G R Gibson, R A Rastall.   

Abstract

AIMS: To investigate the effect of various carbon sources on the production of extracellular antagonistic compounds against two Escherichia coli strains and Salmonella enterica serotype Typhimurium by three canine-derived lactobacilli strains. METHODS AND MATERIALS: Cell-free preparations, pH neutralized, were used in antibiotic disc experiments as an initial screening. The bacteria/carbohydrate combinations that showed inhibition of the growth of those pathogens, were further investigated in batch co-culture experiments. The cell-free supernatants of the cultures, that decreased the population number of the pathogens in the co-culture experiments to log CFU ml-1 <or= 4, were tested for inhibition of the pathogens in pure cultures at neutral and acidic pH.
CONCLUSIONS: The results showed that the substrate seems to affect the production of antimicrobial compounds and this effect could not just be ascribed to the ability of the bacteria to grow in the various carbon sources. L. mucosae, L. acidophilus and L. reuteri, when grown in sugar mixtures consisting of alpha-glucosides (Degree of Polymerization (DP) 1-4) could produce antimicrobial compounds active against all three pathogens in vitro. This effect could not be attributed to a single ingredient of those sugar mixtures and was synergistic. This inhibition had a dose-response characteristic and was more active at acidic pH. SIGNIFICANCE AND IMPACT OF THE STUDY: Knowledge of the effect that the carbon source has on the production of antimicrobial compounds by gut-associated lactobacilli allows the rational design of prebiotic/probiotic combinations to combat gastrointestinal pathogens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962135     DOI: 10.1111/j.1365-2672.2004.02172.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

Review 1.  Prebiotics in vitro digestion by gut microbes, products' chemistry, and clinical relevance.

Authors:  Tolulope Joshua Ashaolu; Joseph O Ashaolu
Journal:  Appl Microbiol Biotechnol       Date:  2020-11-17       Impact factor: 4.813

Review 2.  Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.

Authors:  Mary Ellen Sanders; Daniel J Merenstein; Gregor Reid; Glenn R Gibson; Robert A Rastall
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-11       Impact factor: 46.802

3.  Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli.

Authors:  Pieter Van den Abbeele; Stefan Roos; Venessa Eeckhaut; Donald A MacKenzie; Melanie Derde; Willy Verstraete; Massimo Marzorati; Sam Possemiers; Barbara Vanhoecke; Filip Van Immerseel; Tom Van de Wiele
Journal:  Microb Biotechnol       Date:  2011-10-12       Impact factor: 5.813

4.  Identification of Lactobacillus strains with probiotic features from the bottlenose dolphin (Tursiops truncatus).

Authors:  M A Diaz; E M Bik; K P Carlin; S K Venn-Watson; E D Jensen; S E Jones; E P Gaston; D A Relman; J Versalovic
Journal:  J Appl Microbiol       Date:  2013-08-01       Impact factor: 3.772

Review 5.  Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics - what is the evidence?

Authors:  Silke Schmitz; Jan Suchodolski
Journal:  Vet Med Sci       Date:  2016-01-11

Review 6.  The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.

Authors:  Kelly S Swanson; Glenn R Gibson; Robert Hutkins; Raylene A Reimer; Gregor Reid; Kristin Verbeke; Karen P Scott; Hannah D Holscher; Meghan B Azad; Nathalie M Delzenne; Mary Ellen Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-21       Impact factor: 46.802

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.